R

Rajamanickam

Active Director Managing Director DIN 05270219
DIN 05270219 First appointment Oct 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2004
Shareholding value •••• Premium profile

About Rajamanickam

Data last updated:

Rajamanickam is a Managing Director at Prs Pharmaceuticals Private Limited (since 2004). The company operates in Pharma. Prs Pharmaceuticals Private Limited reported revenue of ₹7.16 Cr (FY 2019).

DIN 05270219
Primary Designation Managing Director
Industry Pharma
First Appointment 04 Oct 2004
Oldest Company Age 22 yrs
Largest company Prs Pharmaceuticals Private Limited · ₹7.16 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prs Pharmaceuticals Private Limited U24231TZ2004PTC011374
Managing Director04 Oct 20042004₹7.16 Cr (FY 2019)Active

Board colleagues of Rajamanickam

Directorship timeline

Open interactive timeline →
Prs Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajamanickam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajamanickam

Rajamanickam currently holds 1 directorship: Prs Pharmaceuticals Private Limited (Managing Director, since 04 Oct 2004, revenue ₹7.16 Cr (FY 2019)).

Rajamanickam was first appointed on 04 Oct 2004 as Managing Director at Prs Pharmaceuticals Private Limited.

The current boards of Rajamanickam's companies include Rajendran (Prs Pharmaceuticals Private Limited), Sekar Raji (Prs Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available